Reduced blood pressure of CFTR-F508del carriers correlates with diminished arterial reactivity rather than circulating blood volume in mice

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Peotta, Veronica A ^a   Bhandary, Prasad ^a   Ogu, Ugochi ^a   Volk, Kenneth A ^a   Roghair, Robert D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CALCIUM ACTIVATED CHLORIDE CHANNEL; CATECHOLAMINE; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ISOPRENALINE; NORADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC STIMULATION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; AORTA CONSTRICTION; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BLOOD VOLUME; CALCIUM MOBILIZATION; CONTROLLED STUDY; DEPRESSED BLOOD PRESSURE; GENE MUTATION; HEMATOCRIT; HETEROZYGOTE; LIGHT DARK CYCLE; MEAN CORPUSCULAR VOLUME; MOUSE; NONHUMAN; PHENOTYPE; TELEMETRY; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CYSTIC FIBROSIS; DRUG EFFECTS; GENETICS; HEMODYNAMICS; METABOLISM; MORTALITY; MUSCLE CONTRACTION; MUTATION; MYOGRAPHY; PATHOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; AORTA; BLOOD PRESSURE; BLOOD VOLUME; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HEMODYNAMICS; HETEROZYGOTE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUTATION; MYOGRAPHY; NOREPINEPHRINE;

EID: 84900444937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096756     Document Type: Article

References (39)

1. Rogan MP, Stoltz DA, Hornick DB (2011) Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment. Chest 139: 1480-1490.
2. Bobadilla JL, Macek M, Fine JP, Farrell PM (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 19: 575-606. (Pubitemid 34556480)
3. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834. (Pubitemid 120035055)
4. Kartner N, Augustinas O, Jensen TJ, Naismith AL, Riordan JR (1992) Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet 1: 321-327.
5. Lake CR, Davis PB, Ziegler M, Kopin IJ (1979) Electrolytes and norepinephrine levels in blood of patients with cystic fibrosis. Clin Chim Acta 92: 141-146. (Pubitemid 9148263)
6. Legris GJ, Dearborn D, Stern RC, Geiss CL, Hopfer U, et al. (1998) Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects. Pediatrics 101: 48-56. (Pubitemid 28030322)
7. Lieberman J, Rodbard S (1975) Low blood pressure in young adults with cystic fibrosis: an effect of chronic salt loss in sweat? Ann Intern Med 82: 806-808.
8. Super M, Irtiza-Ali A, Roberts SA, Schwarz M, Young M, et al. (2004) Blood pressure and the cystic fibrosis gene: evidence for lower pressure rises with age in female carriers. Hypertension 44: 878-883. (Pubitemid 39577415)
9. Rosenthal A, Button LN, Khaw KT (1977) Blood volume changes in patients with cystic fibrosis. Pediatrics 59: 588-594. (Pubitemid 8092814)
10. Michoud MC, Robert R, Hassan M, Moynihan B, Haston C, et al. (2009) Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. Am J Respir Cell Mol Biol 40: 217-222.
11. Guo JJ, Stoltz DA, Zhu V, Volk KA, Segar JL, et al. (2013) Genotype-specific alterations in vascular smooth muscle cell function in cystic fibrosis piglets. J Cyst Fibros doi:10.1016/j.jcf.2013.10.009.
12. Grubb BR, Boucher RC Pathophysiology of gene-targeted mouse models for cystic fibrosis. (1999) Physiol Rev 79: S193-S214. (Pubitemid 29058915)
13. Ostedgaard LS, Meyerholz DK, Chen JH, Pezzulo AA, Karp PH, et al. (2011) The DF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci Transl Med 3: 74ra24.
14. Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, et al. (1995) A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 96: 2051-2064.
15. Haskell SE, Hermann GM, Reinking BE, Volk KA, Peotta VA, et al. (2103) Sertraline exposure leads to small left heart syndrome in adult mice. Pediatr Res 2013; 73: 286-293.
16. Denegri M, Avelino-Cruz JE, Boncompagni S, De Simone SA, Auricchio A, et al. (2012) Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias. Circ Res 110: 663-668.
17. Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, et al. (2007) A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res 75: 69-78. (Pubitemid 46873510)
18. Mock DM, Mock NI, Lankford GL, Burmeister LF, Strauss RG, et al. (2008) Red cell volume can be accurately determined in sheep using a nonradioactive biotin label. Pediatr Res 64: 528-532.
19. Roghair RD, Segar JL, Kilpatrick RA, Segar EM, Scholz TD, et al. (2007) Murine aortic reactivity is programmed equally by maternal low protein diet or late gestation dexamethasone. J Matern Fetal Neonatal Med 20: 833-841. (Pubitemid 47613788)
20. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K (1997) 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5) P3-induced Ca2+ release. J Biochem 122: 498-505. (Pubitemid 27443223)
21. Antigny F, Norez C, Becq F, Vandebrouck C (2011) CFTR and Ca Signaling in Cystic Fibrosis. Front Pharmacol 2: 67.
22. Martins JR, Kongsuphol P, Sammels E, Dahimène S, Aldehni F, et al. (2011) F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis. Biochim Biophys Acta 1812: 1385-1392.
23. Dassios T, Katelari A, Doudounakis S, Mantagos S, Dimitriou G (2013) Respiratory muscle function in patients with cystic fibrosis. Pediatr Pulmonol 48: 865-873.
24. Divangahi M, Balghi H, Danialou G, Comtois AS, Demoule A, et al. (2009) Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 5: e1000586.
25. Baño-Rodrigo A, Salcedo-Posadas A, Villa-Asensi JR, Tamariz-Martel A, Lopez-Neyra A, et al. (2012) Right ventricular dysfunction in adolescents with mild cystic fibrosis. J Cyst Fibros 11: 274-280.
26. Ozcelik N, Shell R, Holtzlander M, Cua C (2013) Decreased right ventricular function in healthy pediatric cystic fibrosis patients versus non-cystic fibrosis patients. Pediatr Cardiol 34: 159-164.
27. Sellers ZM, De Arcangelis V, Xiang Y, Best PM (2010) Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate. J Physiol 588: 2417-2429.
28. Makino M, Hayashi H, Takezawa H, Hirai M, Saito H, et al. (1997) Circadian rhythms of cardiovascular functions are modulated by the baroreflex and the autonomic nervous system in the rat. Circulation 96: 1667-1674. (Pubitemid 27375368)
29. Matchkov VV, Secher Dam V, Bødtkjer DM, Aalkjær C (2013) Transport and function of chloride in vascular smooth muscles. J Vasc Res 50: 69-87.
30. Bartoszewski R, Rab A, Jurkuvenaite A, Mazur M, Wakefield J, et al. (2008) Activation of the unfolded protein response by deltaF508 CFTR. Am J Respir Cell Mol Biol 39: 448-457.
31. Lu JP, Wang Y, Sliter DA, Pearce MM, Wojcikiewicz RJ (2011) RNF170 protein, an endoplasmic reticulum membrane ubiquitin ligase, mediates inositol 1,4,5-trisphosphate receptor ubiquitination and degradation. J Biol Chem 286: 24426-24433.
32. Rab A, Bartoszewski R, Jurkuvenaite A, Wakefield J, Collawn JF, et al. (2007) Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression. Am J Physiol Cell Physiol 292: C756-C766.
33. Sluiter W, Oomens LW, Brand A, Van Furth R (1984) Determination of blood volume in the mouse with 51chromium-labelled erythrocytes. J Immunol Methods 73: 221-225. (Pubitemid 14019676)
34. Hull JH, Garrod R, Ho TB, Knight RK, Cockcroft JR, et al. (2009) Increased augmentation index in patients with cystic fibrosis. Eur Respir J 34: 1322-1328.
35. Poore S, Berry B, Eidson D, McKie KT, Harris RA (2013) Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis. Chest 143: 939-945.
36. Tousson A, Van Tine BA, Naren AP, Shaw GM, Schwiebert LM (1998) Characterization of CFTR expression and chloride channel activity in human endothelia. Am J Physiol 275: C1555-C1564.
37. Robert R, Norez C, Becq F (2005) Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl- transport of mouse aortic smooth muscle cells. J Physiol 568: 483-495. (Pubitemid 41555453)
38. Barbero GJ, Braddock LI (1967) Catecholamines in cystic fibrosis. Lancet 290: 158.
39. Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, et al. (2012) Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax 67: 12-18.